Showing results (91-100 of 278) with videos related to
Sort By:
Pageof 28
AIDS (London, England)|September 24, 2016
Fixed-dose combination emtricitabine/tenofovir/efavirenz initiated during acute HIV infection; 96-week efficacy and durabilityCynthia L Gay, Sarah J Willis, Anna B Cope, et al.Journal of Virology|December 20, 2013
Interaction with cellular CD4 exposes HIV-1 envelope epitopes targeted by antibody-dependent cell-mediated cytotoxicityMaxime Veillette, Anik Désormeaux, Halima Medjahed, et al.Journal of Virology|December 15, 2017
A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus MacaquesAndrew T Jones, Venkateswarlu Chamcha, Sannula Kesavardhana, et al.AIDS Research and Human Retroviruses|October 4, 2017
Intradermal HIV-1 DNA Immunization Using Needle-Free Zetajet Injection Followed by HIV-Modified Vaccinia Virus Ankara Vaccination Is Safe and Immunogenic in Mozambican Young Adults: A Phase I Randomized Controlled TrialEdna Omar Viegas, Nelson Tembe, Charlotta Nilsson, et al.AIDS (London, England)|June 1, 2023
Additional boosting to the RV144 vaccine regimen increased Fc-mediated effector function magnitude but not durabilityZhanna Shubin, Sherry Stanfield-Oakley, Jiraporn Puangkaew, et al.Journal of Virology|June 19, 2015
An Enhanced Synthetic Multiclade DNA Prime Induces Improved Cross-Clade-Reactive Functional Antibodies when Combined with an Adjuvanted Protein Boost in Nonhuman PrimatesMegan C Wise, Natalie A Hutnick, Justin Pollara, et al.AIDS Research and Human Retroviruses|December 29, 2016
Three-Year Durability of Immune Responses Induced by HIV-DNA and HIV-Modified Vaccinia Virus Ankara and Effect of a Late HIV-Modified Vaccinia Virus Ankara Boost in Tanzanian VolunteersAgricola Joachim, Patricia J Munseri, Charlotta Nilsson, et al.AIDS (London, England)|April 14, 2011
Efficacy of NNRTI-based antiretroviral therapy initiated during acute HIV infectionCynthia L Gay, Ashley J Mayo, Chelu K Mfalila, et al.Journal of Virology|October 22, 2020
Priming with DNA Expressing Trimeric HIV V1V2 Alters the Immune Hierarchy Favoring the Development of V2-Specific Antibodies in Rhesus MacaquesSanthi Devasundaram, Margherita Rosati, Antonio Valentin, et al.Journal of Virology|May 6, 2011
An HIV-1 gp120 envelope human monoclonal antibody that recognizes a C1 conformational epitope mediates potent antibody-dependent cellular cytotoxicity (ADCC) activity and defines a common ADCC epitope in human HIV-1 serumGuido Ferrari, Justin Pollara, Daniel Kozink, et al.Pageof 28